, Volume 19, Issue 5, pp 283–291 | Cite as

Inhibition of pro-inflammatory mediators: role of Bacopa monniera (L.) Wettst

  • Vijayan Viji
  • Antony HelenEmail author
Research Article


Bacopa monniera (L.) Wettst is a renowned plant in the Ayurvedic system of medicine. The present study seeks to identify the anti-inflammatory activity of two fractions from the methanolic extract of Bacopa, viz. the triterpenoid and bacoside-enriched fractions. The ability of these two fractions to inhibit the production of pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and interleukin-6 was tested using lipopolysaccharide (LPS)-activated peripheral blood mononuclear cells and peritoneal exudate cells in vitro. We found that triterpenoid and bacoside-enriched fractions significantly inhibited LPS-activated TNF-α, IL-6 and nitrite production in mononuclear cells. Significant antioxidant activity was exhibited by the bacoside enriched fraction compared to the triterpenoid fraction. Carrageenan-induced hind paw oedema assay revealed that triterpenoid and bacoside-enriched fractions exerted anti-oedematogenic effect, while in the arthritis model only the triterpenoid fraction exerted an anti-arthritic potential. The present study provides an insight into the ability of Bacopa monniera to inhibit inflammation through modulation of pro-inflammatory mediator release.


Inflammation Tumor necrosis factor-α Interleukin Oedema Bacopa monniera Arthritis Nitric oxide Bacoside Triterpenoid 



This work was supported by the Kerala State Council for Science, Technology and Environment, Sasthra Bhavan, Thiruvananthapuram, Kerala, India. Standardized Bacopa extract was obtained as a gift from Natural Products Pvt Ltd., Bangalore, India.

Conflict of interest statement

The authors declare that there were no conflicts of interest.


  1. Arend W, Deyer J (1995) Inhibition of production and effects of interleukin-1 and tumor necrosis factor-α in rheumatoid arthritis. Arthritis Rheum 38:151–152PubMedCrossRefGoogle Scholar
  2. Baldwin AS (2001) Series introduction: the transcription factor NF-κB and human disease. J Clin Invest 107:3–6PubMedCrossRefGoogle Scholar
  3. Bezerra MM, Brain SD et al (2004) Reactive nitrogen species scavenging, rather than nitric oxide inhibition, protects from articular cartilage damage in rat zymosan-induced arthritis. Br J Pharmacol 141:172–182PubMedCrossRefGoogle Scholar
  4. Chiou W, Chen C et al (2000) Mechanism of suppression of iNOS expression in RAW264.7 cells by Andrographolide. Br J Pharmacol 129:1553–1560PubMedCrossRefGoogle Scholar
  5. Chowdhury AR, Mandal S et al (2002) Betulinic acid, a potent inhibitor of eukaryotic topoisomerase I: identification of the inhibitory step, the major functional group responsible and development of more potent derivatives. Med Sci Monit 8:254–265Google Scholar
  6. Chung H, Kang M et al (2007) Inhibition of nitric oxide and tumour necrosis factor-α by Moutan cortex in activated mouse peritoneal macrophages. Biol Pharm Bull 30:912–916PubMedCrossRefGoogle Scholar
  7. Darlington LG, Stone TW (2001) Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders. Br J Nutr 85:251–269PubMedCrossRefGoogle Scholar
  8. Dhanasekaran M, Tharakan B et al (2007) Neuroprotective mechanisms of ayurvedic antidementia botanical Bacopa monniera. Phytother Res 21:965–969PubMedCrossRefGoogle Scholar
  9. Feghali CA, Timothy M et al (1997) Cytokines in acute and chronic inflammation. Front Biosci 2:12–26Google Scholar
  10. Ferreira SH, Lorenzetti BB et al (1993) Bradikinin initiates cytokine mediated inflammatory hyperalgesia. Br J Pharmacol 110:1227–1231PubMedGoogle Scholar
  11. Gauldie J, Richards C et al (1987) Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 84:7251–7255PubMedCrossRefGoogle Scholar
  12. Gilliam MB, Sherman MP et al (1993) A spectrophotometric assay for nitrate using NADPH oxidation by Aspergillus nitrate reductase. Anal Biochem 212:359–365PubMedCrossRefGoogle Scholar
  13. Haddad JJ (2002) Antioxidant and prooxidant mechanisms in the regulation of redox-sensitive transcription factors. Cell Signal 14:879–897PubMedCrossRefGoogle Scholar
  14. Hirano T, Akira S et al (1990) Biological and clinical aspects of interleukin-6. Immunol Today 11:443–449PubMedCrossRefGoogle Scholar
  15. Hurst SM, Wilkinson TS (2001) IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 14:705–714PubMedCrossRefGoogle Scholar
  16. Janeway C, Travers P et al (1999) The immune system in health and disease. In: Immunobiology. Garland Publishers, New York, pp 313–316Google Scholar
  17. Jawaheer D, Thomson W et al (1994) Homozygosity for the HLA-DR shared epitope contributes the highest risk for rheumatoid arthritis concordance in identical twins. Arthritis Rheum 37:681–6866PubMedCrossRefGoogle Scholar
  18. Kakkar P, Das B (1984) A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 21:130–134PubMedGoogle Scholar
  19. Kaplanski G, Marin V et al (2003) IL-6: a regulator of the transition from neutrophil to monocytes recruitment during inflammation. Trends Immunol 24:25–29PubMedCrossRefGoogle Scholar
  20. Kim SY, Kim SH et al (2007) Effects of Prunella vulgaris on mast cell-mediated allergic reaction and inflammatory cytokine production. Exp Biol Med 232:921–926Google Scholar
  21. Kopf M, Baumann H et al (1994) Impaired immune and acute-phase responses in interleukin-6 deficient mice. Nature 368:339–342PubMedCrossRefGoogle Scholar
  22. Kotanidou A, Xagorarai A et al (2002) Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of pro-inflammatory molecules in mice. Am J Respir Crit Care Med 165:818–823PubMedGoogle Scholar
  23. Lipsky PE (2006) Interleukin-6 and rheumatic diseases. Arthritis Res Ther 8:4–8CrossRefGoogle Scholar
  24. Lowry OH, Rosebrough NJ et al (1951) Protein measurement with Folin’s phenol reagent. J Biol Chem 193:265–273PubMedGoogle Scholar
  25. MacMicking J, Xie QW et al (1997) Nitric oxide and macrophage function. Ann Rev Immunol 15:323–350CrossRefGoogle Scholar
  26. Nakamura M, Ferreira SH (1987) A peripheral sympathetic component in inflammatory hyperalgesia. Eur J Pharmacol 135:145–153PubMedCrossRefGoogle Scholar
  27. Okhawa H, Oshishi N et al (1979) Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–357CrossRefGoogle Scholar
  28. Rohini G, Devi CS (2008) Bacopa monniera extract induces apoptosis in murine sarcoma cells (S-180). Phytother Res 22:1595–1598PubMedCrossRefGoogle Scholar
  29. Sairam K, Rao CV et al (2001) Prophylactic and curative effects of Bacopa monniera in gastric ulcer models. Phytomedicine 8:423–430PubMedCrossRefGoogle Scholar
  30. Singh A, Singh SK (2009) Reversible suppression of spermatogenesis and fertility without toxic effects. Contraception 79:71–79PubMedCrossRefGoogle Scholar
  31. Schafer A, Chovanova Z et al (2005) Inhibition of COX-1 and COX-2 activity by plasma of human volunteers after ingestion of French maritime pine bark extract (Pycnogenol). Biomed Pharmacother 60:5–9PubMedCrossRefGoogle Scholar
  32. Taibi DM, Bourguignon C (2003) The role of complementary and alternative therapies in managing rheumatoid arthritis. Fam Community Health 26:41–52PubMedGoogle Scholar
  33. Tracey K, Cerami A (1990) Metabolic response to cachectin/TNF. Annals of the New York, Academy of Sciences. New York, pp 325–330Google Scholar
  34. Valko MD, Leibfritz J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44–84PubMedCrossRefGoogle Scholar
  35. Vijayan V, Helen A (2007) Protective activity of Bacopa monniera Linn. on nicotine-induced toxicity in mice. Phytother Res 21:378–381PubMedCrossRefGoogle Scholar
  36. Viji V, Helen A (2008) Inhibition of lipoxygenases and cyclooxygenase-2 enzymes by extracts isolated from Bacopa monniera (L.) Wettst. J Ethnopharmacol 118:305–311PubMedCrossRefGoogle Scholar
  37. Viji V, Kavitha SK et al (2010) Bacopa monniera (L.) Wettst inhibits type II collagen induced arthritis in rats. Phytother Res (PMID: 20309843) (in press)Google Scholar
  38. Yun Y, Han S et al (2003) Immunomodulatory activity of betulinic acid by producing pro-inflammatory cytokines and activation of macrophages. Arch Pharmacol Res 26:1087–1095CrossRefGoogle Scholar
  39. Zhou Y, Peng L et al (2009) Effect of triterpenoid fractions from Bacopa monniera on scopolamine induced memory impairment in mice. Planta Med 75:568–574PubMedCrossRefGoogle Scholar

Copyright information

© Springer Basel AG 2010

Authors and Affiliations

  1. 1.Department of BiochemistryUniversity of KeralaThiruvanthapuramIndia

Personalised recommendations